Mylan Launches Generic Pristiq(R) Tablets

HERTFORDSHIRE, England and PITTSBURGH, March 10, 2017 -- (Healthcare Sales & Marketing Network) -- Mylan N.V. (NASDAQ, TASE: MYL), today announced the U.S. launch of Desvenlafaxine Extended-release Tablets, 50 mg and 100 mg, a generic version of Pfizer's ... Biopharmaceuticals, Generics, Product Launch Mylan, Desvenlafaxine, Pfizer, Pristiq

Source: HSMN NewsFeed - March 10, 2017 Category: Pharmaceuticals Source Type: news